Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: BarbaraT who wrote (7791)	1/15/1999 10:33:00 AM
From: easel	Respond to of 90042

Correct on bond closing early, stock market at regular time.

To: BarbaraT who wrote (7791)	1/15/1999 10:36:00 AM
From: telebob	Read Replies (2) \| Respond to of 90042

HIV - News - AIDS VACCINE - VIENNA, Va., Jan. 15 /PRNewswire/ -- CEL-SCI CORPORATION (Amex: HIV; Berlin: LSR) today announced new data presented by James Talmadge, Ph.D., Professor in the Department of Pathology & Microbiology at the University of Nebraska Medical Center in Omaha, Nebraska, showing that different formulations of CEL-SCI's HGP-30 AIDS vaccine elicited significant Delayed Type Hypersensitivity (DTH) and T-cell proliferation responses in mice. These responses are strong indicators of the induction of cellular immune responses, which many scientists consider essential for an effective AIDS vaccine. HGP-30 and its improved version HGP-30W have already been tested in over 90 volunteers to date. The results were presented at the "Conference on HIV Vaccine Development" in Keystone, Colorado. This study was supported by a grant from the National Institutes of Health (NIH). HGP-30W is currently in a phase II clinical trial in Europe. The HGP-30W amino acid sequence includes at least two CTL epitopes as well as T- and B- cell epitopes, which elicit both cytotoxic (CTL) and helper T-cell immune responses directed to HIV-1. CTLs responding to one of the epitopes within